Rain Oncology Inc. (NASDAQ:RAIN – Get Rating) has been given a consensus rating of “Buy” by the ten brokerages that are presently covering the company, Marketbeat reports. Eight investment analysts have rated the stock with a buy recommendation. The average 1-year target price among analysts that have covered the stock in the last year is […]
Denali Advisors LLC lessened its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Rating) by 41.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,800 shares of the company’s stock after selling 2,700 shares during the quarter. Denali Advisors LLC’s holdings […]
Cardiff Oncology (NASDAQ:CRDF – Get Rating) had its price target decreased by research analysts at HC Wainwright from $15.00 to $14.00 in a research note issued to investors on Tuesday, The Fly reports. Cardiff Oncology Trading Down 4.3 % NASDAQ CRDF opened at $1.80 on Tuesday. The stock has a market capitalization of $80.42 million, […]
Rain Oncology Inc. (NASDAQ:RAIN – Get Rating) was the recipient of a large increase in short interest in March. As of March 31st, there was short interest totalling 909,900 shares, an increase of 42.7% from the March 15th total of 637,800 shares. Currently, 5.6% of the shares of the stock are short sold. Based on […]